Sb Investment Advisers (Uk) LTD Roivant Sciences Ltd. Transaction History
Sb Investment Advisers (Uk) LTD
- $12.6 Billion
- Q2 2025
A detailed history of Sb Investment Advisers (Uk) LTD transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Sb Investment Advisers (Uk) LTD holds 59,952,652 shares of ROIV stock, worth $694 Million. This represents 5.36% of its overall portfolio holdings.
Number of Shares
59,952,652
Previous 61,852,718
3.07%
Holding current value
$694 Million
Previous $624 Million
8.26%
% of portfolio
5.36%
Previous 5.69%
Shares
9 transactions
Others Institutions Holding ROIV
# of Institutions
361Shares Held
456MCall Options Held
8.34MPut Options Held
720K-
Morgan Stanley New York, NY44.7MShares$517 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.3MShares$455 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$409 Million0.01% of portfolio
-
Viking Global Investors LP34.2MShares$396 Million1.22% of portfolio
-
Qvt Financial LP New York, NY29.4MShares$340 Million32.33% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.15B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...